By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Certara Corporation 

St. Louis  Missouri    U.S.A.
Phone: n/a Fax: n/a



Company News
Certara Corporation’s New Muse Invent Allows Chemistry Researchers To Design Drug Candidates That Are Synthetically Feasible 8/11/2014 8:19:54 AM
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014 11:09:07 AM
Certara Corporation Taps Dr. Edmundo Muniz For CEO Post 6/5/2014 6:32:05 AM
Certara Corporation Introduces Pre-Clinical Safety Store To Capture And Validate File-Based Study Data In A CDISC-SEND Database 4/29/2014 9:48:28 AM
Certara Corporation Acquires Specialty Contract Research Organization Synchrogenix 4/15/2014 9:14:55 AM
Certara Corporation Conducts Model-Based Meta-Analysis To Compare The Efficacy And Tolerability Of Two Chronic Nonmalignant Pain Medications 2/24/2014 9:27:30 AM
Certara Corporation Launches Its Phoenix QT+ Cardiac Safety Assessment Tool 2/6/2014 10:38:03 AM
Swedish Pharmaceutical Company Medivir AB (MVRBF) Chooses Certara Corporation’s D360 As Its Global Drug Discovery Platform 1/27/2014 9:34:46 AM
Vector Capital Sells Certara Corporation, A Leading Provider Of Drug Development Software And Services, To Arsenal Capital 12/19/2013 9:54:18 AM
Certara Corporation Has Partnered With Lablogic Systems To Facilitate Faster Drug Discovery Analyses; Certara’s Phoenix Winnonlin Can Now Be Integrated With Lablogic’s Debra Software 12/10/2013 9:50:08 AM